Sanofi v Amgen dispute: Australian update
It’s one of the most consequential pharmaceutical patent disputes in years, one that is being closely watched by practitioners around the world. The patent litigation concerning Amgen’s PCSK9 antibody...
It’s one of the most consequential pharmaceutical patent disputes in years, one that is being closely watched by practitioners...
Read More
Australia second in cleantech growth – tips for in-house counsel
With a landscape so compatible with cleantech solutions, no wonder Australia is a hotbed for innovation. We discuss this and provide tips for IP professionals working in the sector.
With a landscape so compatible with cleantech solutions, no wonder Australia is a hotbed for innovation. We discuss this...
Read More
Skinny labelling in the Australian context: an overview
This article was first published in the 2023 Pharmaceutical Patent Review. Key takeaways In Australia, new indications for known pharmaceuticals may be protected by several different patent claim formats, including method of...
This article was first published in the 2023 Pharmaceutical Patent Review. Key takeaways In Australia, new indications for known pharmaceuticals may be...
Read More
IAM Patent 1000 2024
Spruson & Ferguson has once again been recognised in the 2024 IAM Patent 1000 rankings across the Asia-Pacific, with an outstanding result in multiple countries. We are delighted to announce the...
Spruson & Ferguson has once again been recognised in the 2024 IAM Patent 1000 rankings across the Asia-Pacific, with an outstanding...
Read More
The 2023 Pharmaceutical Patent Review
Welcome to Spruson & Ferguson’s wrap-up of the most notable developments in pharmaceutical patent law in Australia in 2023. The past year saw a number of important Federal Court...
Welcome to Spruson & Ferguson’s wrap-up of the most notable developments in pharmaceutical patent law in Australia in 2023....
Read More
Singapore Becomes an IP Hub for Innovative Russian Enterprises
IPOS International (IPOS-I), the international division of the Intellectual Property Office of Singapore (IPOS), and Russian venture capital fund and accelerator Internet Initiatives Development Fund (IIDF) recently inked a...
IPOS International (IPOS-I), the international division of the Intellectual Property Office of Singapore (IPOS), and Russian venture capital fund...
Read More